These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32599361)

  • 1. The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen.
    Deplano A; Karlsson J; Fowler CJ; Onnis V
    Bioorg Chem; 2020 Aug; 101():104034. PubMed ID: 32599361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen.
    Cipriano M; Björklund E; Wilson AA; Congiu C; Onnis V; Fowler CJ
    Eur J Pharmacol; 2013 Nov; 720(1-3):383-90. PubMed ID: 24120370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen.
    Deplano A; Karlsson J; Svensson M; Moraca F; Catalanotti B; Fowler CJ; Onnis V
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):815-823. PubMed ID: 32200655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode.
    Karlsson J; Morgillo CM; Deplano A; Smaldone G; Pedone E; Luque FJ; Svensson M; Novellino E; Congiu C; Onnis V; Catalanotti B; Fowler CJ
    PLoS One; 2015; 10(11):e0142711. PubMed ID: 26565710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide.
    Fowler CJ; Björklund E; Lichtman AH; Naidu PS; Congiu C; Onnis V
    J Enzyme Inhib Med Chem; 2013 Feb; 28(1):172-82. PubMed ID: 22225576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A binding site for nonsteroidal anti-inflammatory drugs in fatty acid amide hydrolase.
    Bertolacci L; Romeo E; Veronesi M; Magotti P; Albani C; Dionisi M; Lambruschini C; Scarpelli R; Cavalli A; De Vivo M; Piomelli D; Garau G
    J Am Chem Soc; 2013 Jan; 135(1):22-5. PubMed ID: 23240907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of carprofen as a multitarget fatty acid amide hydrolase/cyclooxygenase inhibitor.
    Favia AD; Habrant D; Scarpelli R; Migliore M; Albani C; Bertozzi SM; Dionisi M; Tarozzo G; Piomelli D; Cavalli A; De Vivo M
    J Med Chem; 2012 Oct; 55(20):8807-26. PubMed ID: 23043222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
    Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
    FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and
    Deplano A; Karlsson J; Moraca F; Svensson M; Cristiano C; Morgillo CM; Fowler CJ; Russo R; Catalanotti B; Onnis V
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):940-953. PubMed ID: 33896320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
    Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition.
    Palermo G; Favia AD; Convertino M; De Vivo M
    ChemMedChem; 2016 Jun; 11(12):1252-8. PubMed ID: 26593700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of NSAIDs as potential inhibitors of the fatty acid amide hydrolase I (FAAH-1) using three different primary fatty acid amide substrates in vitro.
    Dongdem JT; Helegbe GK; Opare-Asamoah K; Wezena CA; Ocloo A
    BMC Pharmacol Toxicol; 2022 Jan; 23(1):1. PubMed ID: 34983657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of selective inhibition of canine cyclooxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs.
    Ricketts AP; Lundy KM; Seibel SB
    Am J Vet Res; 1998 Nov; 59(11):1441-6. PubMed ID: 9829404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site.
    Goodman MC; Xu S; Rouzer CA; Banerjee S; Ghebreselasie K; Migliore M; Piomelli D; Marnett LJ
    J Biol Chem; 2018 Mar; 293(9):3028-3038. PubMed ID: 29326169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
    Brideau C; Van Staden C; Chan CC
    Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S; Fowler CJ
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.